glycine has been researched along with Disseminated Intravascular Coagulation in 10 studies
Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This article summarizes the effects of sivelestat on acute lung injury/acute respiratory distress syndrome (ALI/ARDS) or ARDS with coagulopathy, both of which are frequently seen in patients with COVID-19." | 9.05 | Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. ( Avan, R; Bagheri, M; Habtemariam, S; Khataminia, M; Rezai Ghaleno, H; Sadremomtaz, A; Safdari, M; Saghafi, F; Sahebnasagh, A; Talaei, Z, 2020) |
| "Sivelestat is a selective neutrophil elastase inhibitor." | 5.36 | Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. ( Gando, S; Hayakawa, M; Hoshino, H; Katabami, K; Sawamura, A; Sugano, M; Wada, T, 2010) |
| "This article summarizes the effects of sivelestat on acute lung injury/acute respiratory distress syndrome (ALI/ARDS) or ARDS with coagulopathy, both of which are frequently seen in patients with COVID-19." | 5.05 | Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19. ( Avan, R; Bagheri, M; Habtemariam, S; Khataminia, M; Rezai Ghaleno, H; Sadremomtaz, A; Safdari, M; Saghafi, F; Sahebnasagh, A; Talaei, Z, 2020) |
| "Sivelestat is a selective neutrophil elastase inhibitor." | 1.36 | Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients. ( Gando, S; Hayakawa, M; Hoshino, H; Katabami, K; Sawamura, A; Sugano, M; Wada, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahebnasagh, A | 1 |
| Saghafi, F | 1 |
| Safdari, M | 1 |
| Khataminia, M | 1 |
| Sadremomtaz, A | 1 |
| Talaei, Z | 1 |
| Rezai Ghaleno, H | 1 |
| Bagheri, M | 1 |
| Habtemariam, S | 1 |
| Avan, R | 1 |
| Izumida, H | 1 |
| Fujishima, S | 1 |
| Miyoshi, S | 1 |
| Ito, R | 1 |
| Katayama, H | 1 |
| Dote, K | 1 |
| Aibiki, M | 1 |
| Hamada, H | 1 |
| Okura, T | 1 |
| Higaki, J | 1 |
| Hayakawa, M | 1 |
| Katabami, K | 1 |
| Wada, T | 1 |
| Sugano, M | 1 |
| Hoshino, H | 1 |
| Sawamura, A | 1 |
| Gando, S | 1 |
| Zouaoui, K | 1 |
| Dulaurent, S | 1 |
| Gaulier, JM | 1 |
| Moesch, C | 1 |
| Lachâtre, G | 1 |
| Murakami, K | 1 |
| Okajima, K | 1 |
| Uchiba, M | 1 |
| Johno, M | 1 |
| Nakagaki, T | 1 |
| Okabe, H | 1 |
| Takatsuki, K | 1 |
| Smith, RT | 1 |
| Ts'ao, CH | 1 |
| Miloszewski, K | 1 |
| Sheltawy, MJ | 1 |
| Losowsky, MS | 1 |
| Kierulf, P | 1 |
| Godal, HC | 1 |
| Kisker, CT | 1 |
| Rush, R | 1 |
2 reviews available for glycine and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
Topics: Acute Lung Injury; COVID-19; COVID-19 Drug Treatment; Disseminated Intravascular Coagulation; Glycin | 2020 |
[Pharmacological therapies for ARDS].
Topics: Animals; Anticoagulants; Atracurium; Disseminated Intravascular Coagulation; Glycine; Humans; Meta-A | 2013 |
8 other studies available for glycine and Disseminated Intravascular Coagulation
| Article | Year |
|---|---|
Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.
Topics: Aged; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Female; Glycine; Humans; Ma | 2014 |
Sivelestat (selective neutrophil elastase inhibitor) improves the mortality rate of sepsis associated with both acute respiratory distress syndrome and disseminated intravascular coagulation patients.
Topics: Adult; Aged; Disseminated Intravascular Coagulation; Female; Glycine; Humans; Male; Middle Aged; Res | 2010 |
Determination of glyphosate and AMPA in blood and urine from humans: about 13 cases of acute intoxication.
Topics: Accidents; Acidosis; Adult; Aged; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Chro | 2013 |
Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats.
Topics: Amino Acid Chloromethyl Ketones; Amino Acid Sequence; Animals; Anticoagulants; Antithrombin III; Cap | 1996 |
Fibrin degradation products in the postoperative period. Evaluation of a new latex agglutination method.
Topics: Buffers; Disseminated Intravascular Coagulation; Fibrin; Fibrinogen; Glycine; Humans; Immunodiffusio | 1973 |
Fibrinogen-fibrin degradation products and factor XIII.
Topics: Blood Coagulation Tests; Carbon Radioisotopes; Carcinoma; Caseins; Disseminated Intravascular Coagul | 1974 |
Fibrinaemia and multiple thrombi in pancreatic carcinoma. A case studied with quantitative N-terminal analysis.
Topics: Alanine; Blood Coagulation; Blood Coagulation Tests; Disseminated Intravascular Coagulation; Fibrin; | 1972 |
Detection of intravascular coagulation.
Topics: Abortion, Therapeutic; Carbon Isotopes; Disseminated Intravascular Coagulation; Factor XIII; Fibrin; | 1971 |